Our results might provide a rationale to use Oxycodone, a multiple-opioid receptor agonist, as a new therapy to treat myocardial I/R injury via targeting SIGMAR1, suggesting that Oxycodone may be a promising complementary agent for clinically treating ischemic heart disease. This evidence concerns the gene SIGMAR1 and coronary artery disorder.